Goodman Advisory Group, LLC Sorrento Therapeutics, Inc. Transaction History
Goodman Advisory Group, LLC
- $249 Million
- Q1 2025
A detailed history of Goodman Advisory Group, LLC transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Goodman Advisory Group, LLC holds 101,505 shares of SRNE stock, worth $33,496. This represents 0.28% of its overall portfolio holdings.
Number of Shares
101,505Holding current value
$33,496% of portfolio
0.28%Shares
4 transactions
Others Institutions Holding SRNE
# of Institutions
13Shares Held
5.55MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
Lattice Capital Management, LLC51.8KShares$17,0940.01% of portfolio
-
High Point Advisor Group LLC Downers Grove, IL22.3KShares$7,3420.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO20.5KShares$6,7650.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...